Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |